Dr Reddy’s and TR-Pharm in agreement
TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
biosimilar
Generic opportunities outweigh challenges emanating across emerging markets: ICRA
Supported by acquisitions, geographic expansion and steadily expanding product portfolio, the top-10 pharma companies from India…
Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)
Ranibizumab is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), a common degenerative…
Syngene seeks approval for IPO, files DRHP
Offer allows Biocon to monetise its shareholding in Syngene